Entera Total Assets from 2010 to 2024

ENTX Stock

USD 1.64 0.06 3.53%

Entera Bio Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2015-12-31

Previous Quarter

10 M

Current Value

7.7 M

Quarterly Volatility

6.7 M

Yuan Drop

Covid

Check Entera Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Entera Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 97.3 K, Interest Expense of 31.4 M or Selling General Administrative of 5.2 M, as well as many indicators such as Price To Sales Ratio of 79.86, Dividend Yield of 0.0 or PTB Ratio of 1.76. Entera financial statements analysis is a perfect complement when working with Entera Bio Valuation or Volatility modules.

Check out the analysis of Entera Bio Correlation against competitors.

For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.

Latest Entera Bio's Total Assets Growth Pattern

Below is the plot of the Total Assets of Entera Bio over the last few years. Total assets refers to the total amount of Entera Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Entera Bio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Entera Bio's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Entera Bio's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 11.77 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Entera Total Assets Regression Statistics

	Arithmetic Mean	9,406,849
	Geometric Mean	6,981,808
	Coefficient Of Variation	73.79
	Mean Deviation	5,743,992
	Median	10,262,000
	Standard Deviation	6,941,216
	Sample Variance	48.2T
	Range	23.2M
	R-Value	0.77
	Mean Square Error	21.2T
	R-Squared	0.59
	Significance	0.0008
	Slope	1,194,118
	Total Sum of Squares	674.5T

Entera Total Assets History

	2024	13.9 M
	2023	11.8 M
	2022	13.1 M
	2021	26 M
	2020	10.3 M
	2019	16.7 M
	2018	13.3 M

Other Fundumenentals of Entera Bio

Intangibles To Total Assets

Entera Bio Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Property Plant Equipment	Net Invested Capital	Net Working Capital	Current Deferred Revenue	Net Receivables	Capital Surpluse	Long Term Debt Total	Common Stock
Total Assets		0.82	0.81	-0.96	-0.72	-0.25	-0.82	-0.64	0.72	1.0	-0.6	-0.52	0.61	0.85	0.65	-0.13	-0.67	0.65	-0.21	-0.59
Total Stockholder Equity	0.82		1.0	-0.88	-0.88	-0.51	-0.74	-0.96	0.72	0.82	-0.92	-0.72	0.69	1.0	0.4	0.02	-0.84	0.83	-0.36	-0.76
Net Tangible Assets	0.81	1.0		-0.88	-0.9	-0.53	-0.74	-0.97	0.72	0.82	-0.92	-0.75	0.67	0.99	0.4	0.0	-0.86	0.84	-0.41	-0.78
Net Debt	-0.96	-0.88	-0.88		0.83	0.26	0.78	0.74	-0.85	-0.96	0.64	0.63	-0.66	-0.91	-0.52	0.05	0.78	-0.77	0.28	0.7
Retained Earnings	-0.72	-0.88	-0.9	0.83		0.64	0.75	0.85	-0.71	-0.73	0.77	0.9	-0.55	-0.88	-0.29	0.06	0.96	-0.92	0.61	0.91
Accounts Payable	-0.25	-0.51	-0.53	0.26	0.64		0.4	0.58	-0.02	-0.26	0.69	0.63	-0.31	-0.47	-0.17	0.02	0.68	-0.65	0.43	0.74
Long Term Debt	-0.82	-0.74	-0.74	0.78	0.75	0.4		0.61	-0.66	-0.82	0.65	0.58	-0.56	-0.77	-0.2	-0.08	0.66	-0.65	0.32	0.59
Total Liab	-0.64	-0.96	-0.97	0.74	0.85	0.58	0.61		-0.63	-0.64	0.95	0.73	-0.64	-0.95	-0.24	-0.08	0.83	-0.81	0.41	0.75
Short Long Term Debt	0.72	0.72	0.72	-0.85	-0.71	-0.02	-0.66	-0.63		0.72	-0.46	-0.45	0.53	0.77	0.15	0.12	-0.61	0.7	-0.09	-0.55
Total Current Assets	1.0	0.82	0.82	-0.96	-0.73	-0.26	-0.82	-0.64	0.72		-0.6	-0.53	0.59	0.85	0.65	-0.14	-0.68	0.65	-0.21	-0.6
Short Term Debt	-0.6	-0.92	-0.92	0.64	0.77	0.69	0.65	0.95	-0.46	-0.6		0.67	-0.63	-0.89	-0.23	-0.09	0.76	-0.75	0.36	0.68
Intangible Assets	-0.52	-0.72	-0.75	0.63	0.9	0.63	0.58	0.73	-0.45	-0.53	0.67		-0.51	-0.69	-0.2	0.09	0.94	-0.84	0.86	0.81
Property Plant Equipment	0.61	0.69	0.67	-0.66	-0.55	-0.31	-0.56	-0.64	0.53	0.59	-0.63	-0.51		0.69	0.09	0.58	-0.66	0.66	-0.15	-0.55
Net Invested Capital	0.85	1.0	0.99	-0.91	-0.88	-0.47	-0.77	-0.95	0.77	0.85	-0.89	-0.69	0.69		0.39	0.03	-0.83	0.83	-0.33	-0.75
Net Working Capital	0.65	0.4	0.4	-0.52	-0.29	-0.17	-0.2	-0.24	0.15	0.65	-0.23	-0.2	0.09	0.39		-0.56	-0.29	0.21	-0.09	-0.29
Current Deferred Revenue	-0.13	0.02	0.0	0.05	0.06	0.02	-0.08	-0.08	0.12	-0.14	-0.09	0.09	0.58	0.03	-0.56		0.0	0.06	0.25	-0.12
Net Receivables	-0.67	-0.84	-0.86	0.78	0.96	0.68	0.66	0.83	-0.61	-0.68	0.76	0.94	-0.66	-0.83	-0.29	0.0		-0.96	0.64	0.89
Capital Surpluse	0.65	0.83	0.84	-0.77	-0.92	-0.65	-0.65	-0.81	0.7	0.65	-0.75	-0.84	0.66	0.83	0.21	0.06	-0.96		-0.47	-0.85
Long Term Debt Total	-0.21	-0.36	-0.41	0.28	0.61	0.43	0.32	0.41	-0.09	-0.21	0.36	0.86	-0.15	-0.33	-0.09	0.25	0.64	-0.47		0.52
Common Stock	-0.59	-0.76	-0.78	0.7	0.91	0.74	0.59	0.75	-0.55	-0.6	0.68	0.81	-0.55	-0.75	-0.29	-0.12	0.89	-0.85	0.52

Click cells to compare fundamentals

About Entera Bio Financial Statements

Entera Bio investors use historical fundamental indicators, such as Entera Bio's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Entera Bio. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	11.8 M	13.9 M
Intangibles To Total Assets	0.07	0.10

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Entera Stock Analysis

When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC